InvestorsHub Logo
Followers 58
Posts 10142
Boards Moderated 1
Alias Born 09/21/2016

Re: Reyeton post# 137156

Friday, 01/12/2018 8:34:43 AM

Friday, January 12, 2018 8:34:43 AM

Post# of 462083
Brilliant...

Biogen’s MS franchise has been profitable for them, so in that regard, Biogen has succeeded, not in scientific discovery, but in business. Anavex, it seems, has succeeded in scientific discovery, but, up until today, not in business. I just hope that Anavex does not sell its soul to Biogen. The CNS sufferers need Anavex to succeed in its scientific ventures more than they need Biogen to succeed in its business ventures. All my opinion. Investors need to do their own DD.



This would explain everything. BP cannot afford for AVXL science to be correct as an effective treatment w/preventive capabilities---ongoing treatment money are what makes them wealthy...of course. It all fits.

This also explain why we have a continuous uphill battle and presents many questions on ethics and lots of other tricky stuff...

is it possible now that the AD trials path from the past has been allowed to declare failure that the establishment of BP/FDA/Politics, etal . Does this explain the whole delay...new trials...scenario? This same bunch has to say, "OK, we can move on now"...???? We have been thinking it is abut science and process but it REALLY has been about allowing them to gracefully exit the field, which is just what has happened.

Brilliant...you nailed it.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News